Genomics of Klebsiella pneumoniae ST16 producing NDM-1, CTX-M-15, and OXA-232

P Espinal1, E Nucleo2, M Caltagirone2

  • 1Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Servei de Microbiologia Hospital de la Santa Creu i Sant Pau, Institut d'Investigaciò Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.

Abstract

Insights

The Sequence Type 16 (ST16) Klebsiella pneumoniae clone has spread globally, exhibiting variations in carbapenemase genes and plasmids. This adaptable lineage poses a significant public health risk.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a global health threat.
  • Sequence Type 16 (ST16) is an emerging lineage of CRKP with international spread.

Purpose of the Study:

  • To genomically characterize the internationally spreading ST16 CRKP clone.
  • To investigate the genetic basis of carbapenem resistance and plasmid content in ST16 strains.

Main Methods:

  • Whole-genome sequencing of Italian ST16 CRKP isolates.
  • Comparative genomic analysis with international ST16 strains.
  • Phylogenetic analysis, core genome MLST, and plasmid content analysis.

Main Results:

  • ST16 CRKP exhibits variability in carbapenemase genes (blaNDM-1, blaOXA-232).
  • Strains harbor multiple plasmids, including those carrying carbapenemase genes.
  • Genomic and plasmid content differences indicate diverse circulating variants, not a single conserved clone.

Conclusions:

  • The ST16 K. pneumoniae clone is globally disseminated.
  • Its genetic diversity and resistance mechanisms suggest it may become a high-risk clone.

Related Concept Videos

Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
40.7K
Other Nuclides: 31P, 19F, 15N NMR01:16

Other Nuclides: 31P, 19F, 15N NMR

Many organic, inorganic, and biological molecules contain spin-half nuclei such as nitrogen-15, fluorine-19, and phosphorus-31. As a result, NMR studies of these nuclei have found extensive applications in chemical and biological research.
While fluorine-19 and phosphorous-31 have high natural abundances (100%) and positive gyromagnetic ratios, nitrogen-15 has a low natural abundance and a negative gyromagnetic ratio. However, nitrogen-15 is still preferred over nitrogen-14 (which has a...
787
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
895
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.9K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
37.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
816